Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response

Documenti analoghi

• Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
  di: Marotte, Hubert, et al.
  Pubblicazione: (2005)
• Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
  di: Dénarié, Delphine, et al.
  Pubblicazione: (2017)
• Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
  di: Delphine Dénarié, et al.
  Pubblicazione: (2017-01-01)
• Shared epitope and rheumatoid arthritis severity: association with infliximab treatment in a postmarketing study
  di: Marotte, H, et al.
  Pubblicazione: (2003)
• Chronic myeloid leukaemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab
  di: Broussais, F, et al.
  Pubblicazione: (2005)